Ocugen (OCGN)CFO bought ~$26K

~$26K

Approx. value · 21K sh @ $1.23

521K

Holds after · shares reported

Traded

Jun 15, 2026

Filed

Jun 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 4, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
2. May 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
3. May 7, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 3 more items)
4. May 8, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“Effective May 8, 2026, Huma Qamar, M.D., MPH, CMI, separated from Ocugen, Inc. (the “Company”) as its Chief Medical Officer.”
5. May 14, 2026Company filing · Form 8-K · New debt, Unregistered sharesTook on new debt or obligations, and sold new shares without registering them (and 1 more item)
6. May 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective May 29, 2026, Ramesh Ramachandran, CPA, MBA, CMA, resigned as the Chief Accounting Officer of Ocugen, Inc. (the “Company”). Following the resignation of Mr. Ramachandran, who was designated as the Company's principal accounting officer prior to his resignation, on June 3, 2026, Rita Johnson-Greene, MBA, the Company’s Chief Financial Officer, was appointed as the Company’s principal accounting officer.”
7. Jun 15, 2026 · this disclosureInsider · First insider buy since Nov 2024CFO purchased ~$26K of OCGN shares in the open market

What came next

1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 9, 2026Insider · 1 personInsiders: 2 sales (~$589K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ocugen

For Ocugen, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OCGN page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ocugen

• SEC Form 144Oct 9, 2026
• SEC Form 4Sep 12, 2026
• SEC Form 4Sep 12, 2026
• SEC Form 4Dec 2, 2024
• SEC Form 4Nov 26, 2024
• House Clerk periodic transaction reportDec 12, 2022

Everything OQRO holds on this company is on its OCGN page.